Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001076809-25-000072·GLAZER CAPITAL, LLC
Schedule 13G ownership disclosure
SPRINGWORKS THERAPEUTICS INC
Common Stock, par value $0.0001 per share · CUSIP: 85205L107
Event date: 2025-06-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Glazer Capital, LLC
Shares: 0.00 · Class: 0.00%
- Paul J. Glazer
Shares: 0.00 · Class: 0.00%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001076809-25-000072
- Form type
- SCHEDULE 13G
- Filer
- GLAZER CAPITAL, LLC
- CIK
- CIK 1076809
- Filed
- Jul 07, 2025
- Reporting period
- Jun 30, 2025
- Description
- Schedule 13G beneficial ownership